PM Launches Nationwide HPV Vaccination Drive Using Single-Dose Gardasil-4 for Girls

A national programme has introduced Gardasil-4, a quadrivalent single-dose Human Papillomavirus vaccine, for the prevention of cervical cancer. The vaccine provides protection against specific HPV types responsible for cervical cancer.

Human Papillomavirus (HPV) and Gardasil-4 Vaccine:

Dimension	Key Details
Vaccine Used	Gardasil-4, a quadrivalent single-dose Human Papillomavirus vaccine.
Purpose	Provides for prevention of cervical cancer.
Vaccine Effectiveness	Provides 93–100% effectiveness against the targeted HPV types.
Quadrivalent Vaccine	Stimulates an immune response against four different antigens such as four viruses or other microorganisms.
Human Papillomavirus	Comprises a group of about 200 known viruses and provides for a common sexually transmitted infection.
Health Impact of HPV	Persistent infection with high-risk HPV types provides for the cause of cervical cancer.
Natural Infection Outcome	Provides for natural control of infection by the body in about 90% of infected people.
Cervical Cancer Global Status	Provides for the fourth most common cancer in women globally.
Cervical Cancer Status in India	Provides for the second most common cancer among women in India.
Global Burden Share	India comprises about 25% of global cervical cancer deaths and ranks fourth globally in cervical cancer-related morbidity.
Social Impact	Provides disproportionate impact on younger women and accounts for about 20% of children losing their mother to cancer due to cervical cancer.